Details for Patent: 4,444,784
✉ Email this page to a colleague
Summary for Patent: 4,444,784
Title: | Antihypercholesterolemic compounds |
Abstract: | 6(R)-[2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)-polyhydronaphthyl-1')-ethyl]-4 (R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones are prepared by acylation of the corresponding 8'-hydroxy compounds. The products are strong inhibitors of the biosynthesis of cholesterol. |
Inventor(s): | Hoffman; William F. (Lansdale, PA), Smith; Robert L. (Lansdale, PA), Willard; Alvin K. (DE) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 06/217,640 |
Patent Claim Types: see list of patent claims | Compound; Composition; Use; |
Drugs Protected by US Patent 4,444,784
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 4,444,784
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0033538 | ⤷ Sign Up | SPC/GB93/005 | United Kingdom | ⤷ Sign Up |
Austria | 16704 | ⤷ Sign Up | |||
Australia | 548996 | ⤷ Sign Up | |||
Australia | 6657381 | ⤷ Sign Up | |||
Bulgaria | 61418 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |